MusclePharm Corporation (OTCQB:MSLP)
MSLP , one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, announces MuscleGel achieves NSF certification. In addition, MSLP's Recon and Assault nutritional products will be NSF certified within the coming months.
We are extremely pleased MusclePharm's MuscleGel is now NSF certified and look forward to Recon and Assault's future addition to the NSF's list of approved supplements, commented Brad Pyatt, MSLP's Chief Executive Officer. Our Chief Medical Researcher, Dr. Jeffery Stout, Ph.D. and his team of scientists, doctors, and top professional athletes were instrumental in achieving the NSF's certification of MuscleGel, Recon and Assault. These three products provide strong, unique opportunities for us to expand MusclePharm's distribution within the professional athletic community, including the MLB and NFL.
NSF International is an independent, not-for-profit organization that meets the growing demands of athletes, coaches and all those concerned about banned substances in sports supplements. NSF International created the new NSF Certified for Sport Program. This new NSF program is a focused solution designed to minimize the risk that a dietary supplement or sports nutrition product contains banned substances. This program is part of NSF's successful 60-year history of providing certification programs for food, water and consumer goods.
MLB, the MLB Player's Association, NFL, the NFL Player's Association, PGA, LPGA and the CCES have all chosen NSF's Certified for Sport program to help verify the products their athletes use are safer and free of banned substances. NSF GMP for Sport certification verifies that the facility, operations and ingredient sourcing are in compliance with GMP requirements via ongoing audits.
MSLP products are currently available in 1,200 of the top General Nutrition Centers (NYSE:GNC) in the United States, as well as Vitamin Shop. MSLP's award-winning products Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrixare also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.
MSLP's top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, MSLP is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MSLP product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, MSLP has developed six products: ASSAULT, BATTLE FUEL, BULLET PROOF, COMBAT POWDER, RECON and SHRED MATRIX. Two additional products are due in stores in 2010. MSLP products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere. MSLP was founded in 2008 and is based in Aurora, Colorado.
To learn more about visit: http://www.musclepharm.com
BlackRock, Inc. (NYSE:BLK)
BLK announced that the BlackRock Build America Bond Trust (NYSE:BBN), the Trust, a non-diversified closed-end registered investment company that invests primarily in taxable municipal securities known as Build America Bonds, has completed pricing its common share initial public offering, which will close on August 31, 2010, raising approximately $1.015 billion (exclusive of the underwriters' overallotment). The total amount raised could be increased to approximately $1.165 billion assuming full exercise of the underwriters' overallotment, which may not occur.
BLK is a leader in investment management, risk management and advisory services for institutional and retail clients worldwide. At June 30, 2010, BLK's AUM was $3.151 trillion. BLK offers products that span the risk spectrum to meet clients' needs, including active, enhanced and index strategies across markets and asset classes.
To learn more about BLK visit: http://www2.blackrock.com
Baldor Electric Co. (NYSE:BEZ)
S&P SmallCap 600 constituent BEZ will replace Valeant Pharmaceuticals International (NYSE:VRX) in the S&P MidCap 400 index, and Universal Health Realty Trust (NYSE:UHT) has replaced Baldor Electric Co. in the S&P SmallCap 600 index. Valeant Pharmaceuticals is being acquired by S&P Global 1200 constituent Biovail Co. (NYSE:BVF) in a deal expected to close soon, pending final approvals.
BEZ designs, manufactures, and markets industrial electric motors, mechanical power transmission products, drives, and generators. BEZ sells its products and services through independent manufacturer's representatives and sales personnel to original equipment manufacturers and distributors in the United States, as well as in approximately 70 countries. BEZ was founded in 1920 and is based in Fort Smith, Arkansas.
To learn more about BEZ visit: http://www.baldor.com
Baldwin Technology Company, Inc. (Amex:BLD)
BLD, a leader in process automation technology for the global printing industry, announced recently that it has received an order for the Express Newspapers Group, a large U.K. newspaper publisher, through the press manufacturer Koenig & Bauer AG (NYSEARCA:KBA) valued at over $2 million. The move by West Ferry Printers, a subsidiary of Express Newspapers Group, from the facility it has occupied for 24 years in the London Docklands to a new, not yet named site will go hand in hand with a huge investment in presses and auxiliary equipment over the next five years.
BLD, together with its subsidiaries, engages in the development, manufacture, and sale of process automation equipment for the printing and publishing industry. BLD markets its products through direct sales representatives, distributors, and dealer networks to printing press manufacturers, newspaper publishers, and commercial printers primarily in the Americas, Asia, Australia, and Europe. BLD is headquartered in Shelton, Connecticut.
To learn more about BLD visit: http://www.baldwintech.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).
Disclosure: No positions